(Total Views: 577)
Posted On: 03/06/2021 3:25:57 AM
Post# of 151815

Taking into account the FDA’s revised guidance on when to grant an EUA, can anyone give me a good argument why Leronlimab *should not* be given an EUA?
Why not grant one and keep gathering data? Immoral not to during a pandemic IMO.
Why not grant one and keep gathering data? Immoral not to during a pandemic IMO.


Scroll down for more posts ▼